Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C
Iyoda, K.; Kato, M.
Nihon Rinsho. Japanese Journal of Clinical Medicine 62 Suppl 7(Part 1): 502-505
2004
ISSN/ISBN: 0047-1852 PMID: 15359850 Document Number: 571612
Document emailed within 1 workday
Related Documents
Rabinovitz, M.; Block, G.; Finkelstein, S.D. 1996: Alpha-Interferon retreatment of patients with chronic hepatitis C American Journal of Gastroenterology 91(8): 1523-1526Roznovský, L.; Orságová, I.; Petrousová, L.; Mrázek, J.; Kloudová, A.; Kabieszová, L.; Kůrková, J.; Pospísek, M. 2010: Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences Klinicka Mikrobiologie a Infekcni Lekarstvi 16(2): 73-75
Schreiber, Y.S.; Herrera, A.F.; Wilson, D.; Wallengren, K.; Draper, R.; Muller, J.; Dawood, H.; Doucette, S.; Cameron, D.W.; Alvarez, G.G. 2009: Tuberculosis retreatment category predicts resistance in hospitalized retreatment patients in a high HIV prevalence area International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 13(10): 1274-1280
Pol, S. 2002: Treatment of chronic hepatitis C in patients with HIV coinfection: efficacy and tolerance Gastroenterologie Clinique et Biologique 26(Special Issue 2): B264-B273
Ozeki, I.; Karino, Y.; Toyota, J. 2011: Efficacy of the NS3-4A protease inhibitor telaprevir in patients with chronic hepatitis C Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 4): 267-274
Yu, J.; Liu, B.-w.; Lan, L.; Yuan, Y.; Zhang, H.; Jia, C.-h. 2010: Efficacy of peginterferon alpha-2a in combination with ribavirin in treatment of eldly patients with chronic hepatitis C Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 24(5): 373-375
Ma, L.-n.; Chen, X.-y.; Chen, J.; Shen, C.-l.; Wang, J.-t. 2006: Efficacy, influencing factors and safety of PEG-INF alpha-2a (PEG-INF-2a) in the treatment of chronic hepatitis C: analysis of 89 patients Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 20(2): 42-45
Nishikawa, H. 2015: Treatment efficacy and safety in elderly genotype 1b chronic hepatitis C patients with high viral load Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 209-213
Peto, T.J.; Mendy, M.E.; Lowe, Y.; Webb, E.L.; Whittle, H.C.; Hall, A.J. 2014: Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986-90) and in the nationwide immunisation program Bmc Infectious Diseases 14: 7
Pyshkin, S.A.; Malyshev, I.I.; Dimov, P.G. 1986: Indications for surgical treatment of chronic hepatitis and cirrhosis of the liver Klinicheskaia Khirurgiia 9: 29-32
Pongpipat, D.; Suvatte, V.; Assateerawatts, A. 1986: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg Asian Pacific Journal of Allergy and Immunology 4(1): 33-36
Rubin, M.G.; Dover, J.; Glogau, R.G.; Goldberg, D.J.; Goldman, M.P.; Schlessinger, J. 2009: The efficacy and safety of a new U.S. Botulinum toxin type a in the retreatment of glabellar lines following open-label treatment Journal of Drugs in Dermatology: Jdd 8(5): 439-444
Nevens, F.; Van Vlierberghe, H.; D'Heygere, E.; Delwaide, J.; Adler, M.; Henrion, J.; Lenaerts, A.; Hendlisz, A.; Michielsen, P.; Bastens, B.; Brenard, R.; Laureys, A. 2010: A randomized, open-label, multicenter study evaluating the efficacy of peginterferon alfa-2a versus interferon alfa-2a, in combination with ribavirin, in naïve and relapsed chronic hepatitis C patients Acta Gastro-Enterologica Belgica 73(2): 223-228
Spiegel, R.J. 1988: Additional indications for interferon therapy: basal cell carcinoma, carcinoid, and chronic active hepatitis Seminars in Oncology 15(5 Suppl 5: 41-45
Ibragimova, M.M.; Abdurakhmanov, D.T.; Krel', P.E.; Lopatkina, T.N.; Ignatova, T.M.; Popova, I.V. 2003: Efficacy of lamivudine in HBeAg-negative chronic hepatitis B Klinicheskaia Meditsina 81(6): 49-52
Villari, D.; Pernice, M.; Spinella, S.; Squadrito, G.; Rodinò, G.; Brancatelli, S.; Longo, G.; Raimondo, G. 1995: Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study American Journal of Gastroenterology 90(6): 955-958
Techapaitoon, S. 1999: Efficacy of high dose interferon--alpha treatment of chronic hepatitis B Journal of the Medical Association of Thailand 82(11): 1118-1126
Ishibashi, K.; Kashiwagi, T.; Ito, A.; Tanaka, Y.; Nagata, T.; Tamaki, J.; Azuma, M.; Kishida, Y.; Yoshida, A.; Hikiji, A.Y. 1995: Predictive factors for efficacy of interferon therapy in chronic hepatitis type C Hepato-Gastroenterology 42(5): 535-541
Hinoue, Y.; Unoura, M.; Kato, Y.; Kobayashi, K.; Hattori, N. 1984: Effect of interferon on hepatitis B virus infection in patients with chronic active hepatitis Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(2): 205-211
Singh, S.; Malhotra, V.; Sarin, S.K. 2004: Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India Indian Journal of Medical Research 119(4): 145-148